DZ2362A1 - Pharmaceutical compositions containing n-sulfonyl indoline derivatives - Google Patents

Pharmaceutical compositions containing n-sulfonyl indoline derivatives

Info

Publication number
DZ2362A1
DZ2362A1 DZ970212A DZ970212A DZ2362A1 DZ 2362 A1 DZ2362 A1 DZ 2362A1 DZ 970212 A DZ970212 A DZ 970212A DZ 970212 A DZ970212 A DZ 970212A DZ 2362 A1 DZ2362 A1 DZ 2362A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical compositions
compositions containing
indoline derivatives
sulfonyl
sulfonyl indoline
Prior art date
Application number
DZ970212A
Other languages
French (fr)
Inventor
Jean-Claude Gautier
Simon John Fuller
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DZ2362A1 publication Critical patent/DZ2362A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DZ970212A 1996-12-05 1997-12-03 Pharmaceutical compositions containing n-sulfonyl indoline derivatives DZ2362A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (en) 1996-12-05 1996-12-05 PHARMACEUTICAL COMPOSITIONS CONTAINING N-SULFONYL INDOLINE DERIVATIVES

Publications (1)

Publication Number Publication Date
DZ2362A1 true DZ2362A1 (en) 2002-12-28

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970212A DZ2362A1 (en) 1996-12-05 1997-12-03 Pharmaceutical compositions containing n-sulfonyl indoline derivatives

Country Status (25)

Country Link
EP (1) EP0941090A1 (en)
JP (1) JP2000507618A (en)
KR (1) KR20000069308A (en)
CN (1) CN1239887A (en)
AR (1) AR009651A1 (en)
AU (1) AU716575B2 (en)
BR (1) BR9712406A (en)
CA (1) CA2273990A1 (en)
CO (1) CO4910129A1 (en)
DZ (1) DZ2362A1 (en)
EE (1) EE9900206A (en)
FR (1) FR2756736B1 (en)
HU (1) HUP0001386A3 (en)
ID (1) ID23373A (en)
IL (1) IL129936A0 (en)
IS (1) IS5062A (en)
MY (1) MY132819A (en)
NO (1) NO992724D0 (en)
NZ (1) NZ335750A (en)
RU (1) RU2174394C2 (en)
SK (1) SK75599A3 (en)
TR (1) TR199901702T2 (en)
WO (1) WO1998024430A1 (en)
YU (1) YU23099A (en)
ZA (1) ZA9710919B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (en) * 1998-11-16 2000-12-08 Sanofi Sa PROCESS FOR THE PREPARATION OF (2S) -1 - [(2R, 3S) -5-CHLORO-3- (2- CHLOROPHENYL) -1- (3,4-DIMETHOXY BENZENESULFONYL) -3-HYDROXY- 2,3-DIHYDRO- 1H-INDOLE-2-CARBONYL] PYRROLIDINE-2-CARBOXAMIDE, ITS SOLVATES AND / OR HYDRATES
DE19913692A1 (en) * 1999-03-25 2000-09-28 Basf Ag Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
ATE329579T1 (en) 1999-11-12 2006-07-15 Abbott Lab SOLID DISPERSION WITH RITONAVIR, FENOFIBRATE OR GRISEOFULVIN
FR2805992A1 (en) * 2000-03-08 2001-09-14 Sanofi Synthelabo Oral administration of N-sulfonyl-indoline derivative to treat central nervous system, cardiovascular or gastric disorders, using polyethylene glycol, polysorbate and poloxamer as solubilizers for high bioavailability
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying active ingredient formulation and use of this formulation
ITMI20011338A1 (en) 2001-06-26 2002-12-26 Farmatron Ltd ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (en) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
KR102139338B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound
KR102139339B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (en) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. WATER-FREE EMULSIONS AND USE THEREOF
FR2679903B1 (en) * 1991-08-02 1993-12-03 Elf Sanofi DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.

Also Published As

Publication number Publication date
SK75599A3 (en) 2000-08-14
IS5062A (en) 1999-06-01
EE9900206A (en) 1999-12-15
TR199901702T2 (en) 1999-09-21
NO992724L (en) 1999-06-04
NO992724D0 (en) 1999-06-04
CO4910129A1 (en) 2000-04-24
CN1239887A (en) 1999-12-29
IL129936A0 (en) 2000-02-29
BR9712406A (en) 1999-08-31
HUP0001386A2 (en) 2001-04-28
EP0941090A1 (en) 1999-09-15
AU5326298A (en) 1998-06-29
MY132819A (en) 2007-10-31
ID23373A (en) 2000-04-20
NZ335750A (en) 2001-06-29
FR2756736B1 (en) 1999-03-05
CA2273990A1 (en) 1998-06-11
HUP0001386A3 (en) 2002-03-28
ZA9710919B (en) 1999-06-04
RU2174394C2 (en) 2001-10-10
KR20000069308A (en) 2000-11-25
FR2756736A1 (en) 1998-06-12
WO1998024430A1 (en) 1998-06-11
YU23099A (en) 1999-11-22
JP2000507618A (en) 2000-06-20
AR009651A1 (en) 2000-04-26
AU716575B2 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
DK0747050T3 (en) Pharmaceutical compositions containing irbesartan
DZ2361A1 (en) 6-phenylpyridyl-2-amine derivatives and pharmaceutical compositions containing them
CY2005007I1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DARIFENACINE
ID22973A (en) PHARMACEUTICAL COMPOSITION OF ORAL PROVISION FROM N-PIPERIDINO-3-PIRAZOLKARBOKSAMIDA, SALT AND ITS SOLVATES
IS4706A (en) pharmaceutical compositions
DZ2614A1 (en) Topical pharmaceutical compositions containing resorcinol derivatives.
PT907364E (en) PHARMACEUTICAL COMPOSITION OF SUSTAINED LIBERTACAO
DK0936913T3 (en) Oral pharmaceutical composition containing ibandronate
PT1066027E (en) PHARMACEUTICAL COMPOSITION OF TOPIRAMATO
ID18663A (en) COMPOSITION OF PHARMACEUTICAL PLATED PHARMACEUTICALS
MA24466A1 (en) COMPOSITIONS CONTAINING TETRAHYDROLISTATIN
IL120699A0 (en) Indole derivatives and pharmaceutical compositions containing them
FR2775596B1 (en) NEW PHARMACEUTICAL COMPOSITIONS
MA26553A1 (en) ALPHA-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IS2340B (en) Solid pharmaceutical composition containing benzofuran derivatives
MA26507A1 (en) AEROSOL PHARMACEUTICAL COMPOSITIONS
BR9604951A (en) Pharmaceutical composition containing n-phosphonoglycine derivatives to inhibit the development of viruses and cancers
ITMI982222A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENERPHINE
HUP0002324A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
FI962969A (en) Indole derivatives as agonists of 5-HT1
DZ2362A1 (en) Pharmaceutical compositions containing n-sulfonyl indoline derivatives
IL118424A0 (en) Pharmaceutical compositions containing benzimidazole derivative
EE9800400A (en) Pharmaceutical compositions containing diclofenac
IS2515B (en) pharmaceutical compositions
PT941100E (en) PHARMACEUTICAL COMPOSITIONS